A simple, secure interface for the care team
Resilience's remote monitoring platform, a class IIa medical device, enables healthcare professionals to improve remote monitoring of their patients by giving them the possibility of :
- Measure treatment-related symptoms with tailored e-PRO questionnaires
- Follow their evolution and be notified in real time according to the severity of reported side effects
- Quickly identify at-risk patients and adapt treatments to their needs
Pr Ethan Basch
Oncologist and Director of Research, University of North Carolina
"It's our job to take care ofour patients, whether they're in clinic or at home. The only way to take careof them is to understand what they go through on a daily basis, and we needtools to help us do that."
Dr Thomas Grellety
Oncologist and Head of Department, Centre Hospitalier de la Côte Basque
"It provides us with continuous feedback and a way to focus our actions, including for those of our Advanced Practice Nurse, for specific patients in demand."
Mme Nathanaëlle Leprevier
Nurse coordinator, Centre Hospitalier de Valenciennes
"Resilience allows us toanticipate the scheduling of supportive care when patients come to the dayhospital. Now everyone has access to a regular follow-up. There's no goingback."
Dr Thomas Grellety
Oncologist and Head of Department, Centre Hospitalier de la Côte Basque
"You'll now be able to devotemedical and paramedical time simply for needs that emerges and when theyemerge."
Dr Antoine Lemaire
Head of Oncology and Medical Specialties, Centre Hospitalier de Valenciennes
"I see remote monitoring as atool that will enable us to be more efficient and to have a vision of acontinuum of care for patients."
Dr Antoine Lemaire
Head of Oncology and Medical Specialties, Centre Hospitalier de Valenciennes
"The idea is that we can have a vision of the patient's progression of care, even outside of hospital walls, and anticipate problems as they come."
Dr Joana Ribiero
Medical oncologist, Gustave Roussy
"Remote monitoring has greatlyimproved the quality of care here (...) It's a win for patients and a win forus."
Dr Laura Polastro
Medical oncologist in gynecology and senology, Institut Jules Bordet
"Resilience is an easy tool tounderstand and is greatly endorsed by patients. It is therefore a veryinteresting to monitor my patients."
Dr Barbara Pistilli
Head of the Breast Pathology Committee, Gustave Roussy
"It's a great resource for ourpatients because they have a very personalized follow-up tailored to theirneeds. It's also a great resource for us professionals as we don't have such agap between two consultations, or between two chemotherapy sessions."
Facilitating care coordination and maintaining links with patients
99% of the time, a patient is not under the supervision of his or her oncologist. The link between patients and their care teams can weaken. Strengthening it has become a necessity to avoid, for example, non-compliance with treatment. Resilience enables patients to benefit from local support, even at a distance.
92%
Of healthcare professionals find that Resilience integrates appropriately into their organization.*
72%
Of nurses report that Resilience improves communication with their patients.*
62%
Of doctors report that Resilience can detect early deterioration or the onset of undesirable events.
Sources
*Satisfaction survey conducted by Resilience among healthcare professionals using the solution - December 2022
e-PRO questionnaires tailored to your patients' needs
Created by oncologists and researchers, the construction of our adapted e-PRO (electronic Patient-Reported Outcome) questionnaires strictly follows ESMO guidelines. Applicable to all types of cancer, they are comprised of generic and specific questions that capture the impact of different tumor types and/or treatments, with a level of evidence and a grade of recommendation [I,A].
.webp)
.webp)
.webp)
Understanding and monitoring to optimize medical intervention
Thanks to real-time data collection and an intelligent alert system, the care team can detect and predict relapses, toxicities or complications experienced by patients. Resilience also enables healthcare teams to proactively adapt management and improve treatment coordination.
1. Le patient évalue ses symptômes
Réception des questionnaires e-PRO à fréquence régulière
Déclaration et mesure des symptômes ressentis au quotidien
Accès à des contenus et programmes de soins de support digitaux élaborés par des experts et professionnels de santé
Collecte de données en temps réel
2. Le personnel infirmier traite les alertes
Gradation des symptômes et système d'alertes intelligent
Identification des problématiques rencontrées et priorisation de la file active
Contact et orientation pro-active des patients
Mise en place d'une prise en charge adaptée
3. L'oncologue intervient si nécessaire
Adaptation du traitement
Prescription nouvelle ou renouvelée
Consultation ou hospitalisation
Scientifically proven clinical and organizational benefits
Remote medical monitoring in oncology has proven its impact on patient health and care organization through several French and international clinical trials.
CLINICAL BENEFITS FOR PATIENT'S HEALTH
4%
Relative Dose Intensity (1)
-9.3%
Treatment-related toxicities (grade ≥3) (1)
+5.2%
Of months of overall survival (2)
BENEFITS FOR PATIENT CARE
-1.62
Day of hospitalization (1)
-6.9
Emergency room use (1)
Sources
(1) Mir, O., Ferrua, M., Fourcade, A. et al. Digital remote monitoring plus usual care versus usual care in patients treated with oral anti-cancer agents: the randomized phase 3 CAPRI trial. Nat Med (2022). doi.org/10.1038/s41591-022-01788-1.
(2) Basch, Ethan et al. "Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A RandomizedControlled Trial." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 34.6 (2016): 557-65. doi:10.1200/JCO.2015.63.0830
Safety and regulatory compliance as mainstays
Our software has been designed in accordance with the most stringent international standards in terms of quality management, information security management system security (ISO 27001:2022 certification) and medical device design. We also place a great emphasis on protecting our users' personal data and complying with European regulations.
Dispositif médical de classe IIa
- Dispositif médical portant le marquage CE (classe IIa) sous la directive MDD 93/42
- Certifié par l’organisme notifié GMED et déclaré auprès de l'ANSM
- Conforme au MDR européen 2017/745 (article 120)
- Seule plateforme française certifiée classe IIa
Collecte de données sécurisée
- Solutions développées en prenant en compte la protection des données de nos utilisateurs (professionnels de santé et patients)
- Accompagnement renforcé de la CNIL durant toute l'année 2021
- Conformité au RGPD
- Données de santé hébergées en France par des hébergeurs Agréés Données de Santé (Ecritel, OVHcloud)
Meet our teams at upcoming events
The Resilience team is at your service
Amina, Eugénie and Timothée, our Partnership Managers, will be happy to tell you more about Resilience and telemonitoring in oncology, and the impact of telemonitoring in oncology.
.webp)
Contact us
Are you a healthcare professional interested in finding out more about Resilience? We'd love to hear from you!
